These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10941144)

  • 1. Positron emission tomography of radioligand binding in porcine striatum in vivo: haloperidol inhibition linked to endogenous ligand release.
    Ishizu K; Smith DF; Bender D; Danielsen E; Hansen SB; Wong DF; Cumming P; Gjedde A
    Synapse; 2000 Oct; 38(1):87-101. PubMed ID: 10941144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDMA-evoked changes in [11C]raclopride and [11C]NMSP binding in living pig brain.
    Rosa-Neto P; Gjedde A; Olsen AK; Jensen SB; Munk OL; Watanabe H; Cumming P
    Synapse; 2004 Sep; 53(4):222-33. PubMed ID: 15266554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDMA-evoked changes in the binding of dopamine D(2) receptor ligands in striatum of rats with unilateral serotonin depletion.
    Ostergaard SD; Alstrup AK; Gramsbergen JB; Minuzzi L; Pedersen K; Jensen SB; Doudet D; Cumming P
    Synapse; 2010 Jan; 64(1):70-82. PubMed ID: 19768811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrepancies in apparent dopamine D2 receptor occupancy between 3H-raclopride and 3H-N-methylspiperone.
    Inoue O; Kobayashi K; Hosoi R; Yamaguchi M; Gee A
    J Neural Transm (Vienna); 1999; 106(11-12):1099-104. PubMed ID: 10651106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No elevated D2 dopamine receptors in neuroleptic-naive schizophrenic patients revealed by positron emission tomography and [11C]N-methylspiperone.
    Nordström AL; Farde L; Eriksson L; Halldin C
    Psychiatry Res; 1995 Aug; 61(2):67-83. PubMed ID: 7480390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of 3H-N-methylspiperone binding but not 3H-raclopride binding in mouse striatum by MK-801: evidence that factors other than competition by endogenous dopamine are responsible for changes in D2 receptor binding in vivo. Short communication.
    Inoue O; Wakahara S; Kobayashi K; Gee A
    J Neural Transm (Vienna); 1999; 106(2):131-7. PubMed ID: 10226933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of rolipram on in vivo dopamine receptor binding.
    Hosoi R; Ishikawa M; Kobayashi K; Gee A; Yamaguchi M; Inoue O
    J Neural Transm (Vienna); 2002 Sep; 109(9):1139-49. PubMed ID: 12203041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the in vitro receptor binding properties of N-[3H]methylspiperone and [3H]raclopride to rat and human brain membranes.
    Hall H; Wedel I; Halldin C; Kopp J; Farde L
    J Neurochem; 1990 Dec; 55(6):2048-57. PubMed ID: 1977888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of endogenous dopamine on kinetics of [3H]N-methylspiperone and [3H]raclopride binding in the rat brain.
    Young LT; Wong DF; Goldman S; Minkin E; Chen C; Matsumura K; Scheffel U; Wagner HN
    Synapse; 1991 Nov; 9(3):188-94. PubMed ID: 1776131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained withdrawal allows normalization of in vivo [11C]N-methylspiperone dopamine D2 receptor binding after chronic binge cocaine: a positron emission tomography study in rats.
    Maggos CE; Tsukada H; Kakiuchi T; Nishiyama S; Myers JE; Kreuter J; Schlussman SD; Unterwald EM; Ho A; Kreek MJ
    Neuropsychopharmacology; 1998 Aug; 19(2):146-53. PubMed ID: 9629568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of putaminal dopamine D2 receptors in early Parkinson's disease: a comparative PET study with [11C] raclopride and [11C]N-methylspiperone.
    Kaasinen V; Ruottinen HM; Någren K; Lehikoinen P; Oikonen V; Rinne JO
    J Nucl Med; 2000 Jan; 41(1):65-70. PubMed ID: 10647606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competition between 11C-raclopride and endogenous dopamine in Parkinson's disease.
    Ishibashi K; Ishii K; Oda K; Mizusawa H; Ishiwata K
    Nucl Med Commun; 2010 Feb; 31(2):159-66. PubMed ID: 19966595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMDA antagonist effects on striatal dopamine release: positron emission tomography studies in humans.
    Kegeles LS; Martinez D; Kochan LD; Hwang DR; Huang Y; Mawlawi O; Suckow RF; Van Heertum RL; Laruelle M
    Synapse; 2002 Jan; 43(1):19-29. PubMed ID: 11746730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A consideration of the dopamine D2 receptor monomer-dimer equilibrium and the anomalous binding properties of the dopamine D2 receptor ligand, N-methyl spiperone.
    Logan J; Fowler JS; Dewey SL; Volkow ND; Gatley SJ
    J Neural Transm (Vienna); 2001; 108(3):279-86. PubMed ID: 11341479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo binding of spiperone and N-methylspiperone to dopaminergic and serotonergic sites in the rat brain: multiple modeling and implications for PET scanning.
    Swart JA; van der Werf JF; Wiegman T; Paans AM; Vaalburg W; Korf J
    J Cereb Blood Flow Metab; 1990 May; 10(3):297-306. PubMed ID: 1970341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-(2'-[18F]fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans.
    Barrio JR; Satyamurthy N; Huang SC; Keen RE; Nissenson CH; Hoffman JM; Ackermann RF; Bahn MM; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):830-9. PubMed ID: 2531146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of Neuroreceptors in the living human brain. II. Inhibition studies of receptor density and affinity.
    Wong DF; Gjedde A; Wagner HN; Dannals RF; Douglass KH; Links JM; Kuhar MJ
    J Cereb Blood Flow Metab; 1986 Apr; 6(2):147-53. PubMed ID: 2937795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of neuroreceptors in the living human brain. I. Irreversible binding of ligands.
    Wong DF; Gjedde A; Wagner HN
    J Cereb Blood Flow Metab; 1986 Apr; 6(2):137-46. PubMed ID: 2937794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deriving the therapeutic concentrations for clozapine and haloperidol: the apparent dissociation constant of a neuroleptic at the dopamine D2 or D4 receptor varies with the affinity of the competing radioligand.
    Seeman P; Van Tol HH
    Eur J Pharmacol; 1995 Oct; 291(2):59-66. PubMed ID: 8566176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET measurement of D2 and S2 receptor binding of 3-N-[( 2'-18F]fluoroethyl)spiperone in baboon brain.
    Coenen HH; Wienhard K; Stöcklin G; Laufer P; Hebold I; Pawlik G; Heiss WD
    Eur J Nucl Med; 1988; 14(2):80-7. PubMed ID: 2968911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.